⌘K

Home/Filings/4/0001213900-23-043125

4//SEC Filing

Schuyler Kevin 4

Accession 0001213900-23-043125

CIK 0001513525other

View on SEC.gov Company Profile

Filed

May 24, 8:00 PM ET

Accepted

May 25, 4:45 PM ET

Size

5.5 KB

Accession

0001213900-23-043125

Insider Transaction Report

Form 4

Period: 2023-05-23

ADIAL PHARMACEUTICALS, INC.ADIL

Director

Transactions

Award
Stock Option (Right to Buy)
2023-05-23+50,000→ 50,000 total
Exercise: $0.30From: 2023-05-23Exp: 2033-05-23→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

Entity typeother

Related Parties

1

filerCIK 0001718094

Filing Metadata

Form type: 4
Filed: May 24, 8:00 PM ET
Accepted: May 25, 4:45 PM ET
Size: 5.5 KB

View on SEC.gov